Migraine Clinical Trials in Los Angeles, California

5 studies are recruiting for migraine in Los Angeles, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

    This goal of this study is to compare three medications used for migraine preventive treatment. This study will compare atogepant, a newer migraine preventive medication, with two older preventive medications, topiramate and propranolol. It will be determined if one works better and is more tolerab…

    Stage
    Phase 4
    Ages
    18 to 70
    Site
    Keck School of Medicine of USC, Los Angeles, California
    Locations
    36 in total
    Run by
    Mayo Clinic

    See if you can join NCT06972056 on ClinicalTrials.gov

  2. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in children. The purpose of this study is to evaluate how s…

    Stage
    Phase 3
    Ages
    6 to 17
    Site
    Children's Hospital Los Angeles /ID# 230596, Los Angeles, California
    Locations
    129 in total
    Run by
    AbbVie

    See if you can join NCT05125302 on ClinicalTrials.gov

  3. Study of EVO756 in Adults With Migraine

    This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.

    Stage
    Phase 2
    Ages
    18 to 64
    Site
    CA Medical Clinic for Headache, Los Angeles, California
    Locations
    26 in total
    Run by
    Evommune, Inc.

    See if you can join NCT07616128 on ClinicalTrials.gov

  4. A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    This is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with placebo, in the acute treatment of migraine.

    Stage
    Phase 3
    Ages
    18 to 75
    Site
    Downtown L.A. Research Center, Inc., Los Angeles, California
    Locations
    113 in total
    Run by
    Kallyope Inc.

    See if you can join NCT07645924 on ClinicalTrials.gov

  5. A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

    The purpose of this Phase 2 study is to evaluate the safety and efficacy of SC MEDI0618 compared to placebo in participants with episodic migraine.

    Stage
    Phase 2
    Ages
    18 to 70
    Site
    Clinical Research Institute, LCC, Los Angeles, California
    Locations
    54 in total
    Run by
    AbbVie

    See if you can join NCT06602479 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.